PARP7 inhibitor BY101921

{
  "id": "MLC-T-ONC-015849",
  "term": "PARP7 inhibitor BY101921",
  "field": "Oncology and biomedicine",
  "definition": "An orally available inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) 7, with potential immunomodulating and antineoplastic activities. Upon oral administration, PARP7 inhibitor BY101921 targets, binds to, and inhibits the activity of PARP7, which restores type I interferon (IFN) signaling. This may lead to the induction of both innate and adaptive immune responses, and the inhibition of tumor growth and proliferation. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins that signal and recruit other proteins to repair damaged DNA.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/parp7-inhibitor-by101921/"
}